scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 167.3% | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 68.7% | 72% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -213.1% | -338.9% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -234.4% | -403.2% | – | – |
| EPS Diluted | -1.91 | -1.42 | -1.3 | -1.02 |
| % Growth | -34.5% | -9.2% | -27.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |